Biodesix Secures $17,756,512 New Financing Round

  • Feed Type
  • Date
    2/16/2016
  • Company Name
    Biodesix
  • Mailing Address
    2970 Wilderness Place Boulder, CO 80301 USA
  • Company Description
    Biodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease.
  • Website
    http://www.biodesix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $17,756,512
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Offer and sale of Series F Preferred Stock, conversion of Convertible Promissory Notes and offer and sale of contingent value rights relating to revenue from one of the Issuer’s products. 24 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor

Trending on Xconomy